Quarterly report pursuant to Section 13 or 15(d)

Goodwill and In-process R&D

v3.21.2
Goodwill and In-process R&D
9 Months Ended
Sep. 30, 2021
Goodwill and In-process R&D  
Goodwill and In-process R&D

7. Goodwill and In-Process R&D

Goodwill of $2.2 million and in-process R&D of $5.9 million were recorded in connection with the acquisition of Pelican, as described in Note 2. The Company performs an annual impairment test at the reporting unit level as of April 1st of each fiscal year. No impairment was recorded during the quarters ended September 30, 2021 or 2020.